Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Naloxone Market, by Drug Type (Branded and Generic), by Administration (Intranasal Administration, Intramuscular Administration, and Intravenous Administration), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Geography - Size, Share, Outlook, and Opportunity Analysis 2018-2026

Published Date : Aug 2018

Naloxone Market- Insights Naloxone is a medication which is mainly used to reverse opioid overdose such as morphine and heroine. Naloxone is an opioid antagonist and the U.S. Food and Drug Administration (FDA

Coherent Market Insights
Botanical and Plant Derived Drugs Market, by Source (Plant, Algae, Macroscopic fungi, and Others), by Dosage Form (Pills, Tablets, Capsules, and Injection), by Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), by Region - Global Forecast to 2026

Published Date : Jun 2018

Botanical and Plant Derived Drugs Market - Global Industry Insights The botanical and plant derived drugs are obtained from medicinal plants, which contain algae, microscopic fungi or any vegetable material.

Coherent Market Insights
Chronic Kidney Disease Drugs Market, by Drug Class (ACE Inhibitors, B- Blockers, Calcium Channel Blockers, Diuretics, Erythropoiesis-Stimulating Agents (ESAs), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Forecast to 2026

Published Date : Jun 2018

Chronic Kidney Disease Drugs Market – Insights Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and exc

Coherent Market Insights
Pain Management Drugs Market, by Drug Class (Opioids, NSAIDs, Anticonvulsants, Antidepressants, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Forecast to 2026

Published Date : May 2018

Pain Management Drugs Market – Insights Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications

Coherent Market Insights
Herbal Medicinal Products Market, by Product Type (Ayurvedic Medicines, Homeopathic Medicines, Chinese Medicines and Aromatherapy), by Dosage Form (Capsules/Tablets, Syrups, Powders, Ointment, others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and others), and by Region - Global Forecast to 2025

Published Date : May 2018

Herbal Medicinal Products Market Insights- No chemical, high safety The herbal medicines product are the first choice among people to avoid adverse health effects. According to the Council for Scientific and

Coherent Market Insights
Dementia Drugs Market, by Drug Class (MAO Inhibitors, Cholinesterase Inhibitors, and Glutamate Inhibitors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Geography - Global Forecast to 2026

Published Date : May 2018

Dementia Drugs Market – Insights Dementia is a form of disease that affects the functioning of the brain resulting in decline in memory or other thinking skills. Alzheimer’s disease is the most co

Coherent Market Insights
Small Molecule Prefilled Syringes Market, by Drug Class (Cardiovascular Drugs, Neurology Drugs, Analgesics, Adjuvants, and Others), By Material (Glass, and Plastic & Polymer) and Region - Global Trends and Forecast to 2025

Published Date : May 2018

Small Molecule Prefilled Syringes Market Insights Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syring

Coherent Market Insights
Alzheimer’s Drugs Market, by Drug (Donepezil, Rivastigmine, Galantamine and Memantine), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Forecast to 2025

Published Date : Mar 2018

Alzheimer’s Drugs Market - Young Prospect for Aging Patient Alzheimer’s is a form of dementia, which affect behavior, thinking, and memory of patient. The progression of disease is slow and it deg

Coherent Market Insights
Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

Published Date : Feb 2018

Acute Otitis Media Treatment Market - Insights Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptom

Coherent Market Insights
Facial Injectables Market, by Product Type (Dermal Fillers, and Anti-wrinkle Injection), by Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others) by End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Facial Injectables Market – Restoring the Radiance of Youth Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial i

Coherent Market Insights
Empty Capsules Market, by Product Type (Gelatin Capsules (Porcine, Bovine, Bone Meal), Non-Gelatin Capsules (HPMC, Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Empty Capsules Market - Insights Capsules offer a viable alternative to tablets as an oral delivery of therapeutic compounds. Empty capsules are oral dosage forms, which based on the type of manufacturing mat

Coherent Market Insights
Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents and Others), by Route of Administration (Oral and Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal c

Coherent Market Insights
Peptide Based Infection Therapeutics Market by Drug (Telaprevir, and Boceprevir), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Excessive and inappropriate use of antibiotics is creating antibiotic resistance among affected population at present. Therefore, the urge of developing novel therapies in fighting infections is increasing. A novel, peptide based therapies for treating infections has

Coherent Market Insights
Oncology Drug Pipeline Analysis Market, by Drug Class (Immunotherapy, Monoclonal Antibody, Antibody-Drug Conjugate, and Others), by Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others), by Route of Administration (Oral and Parenteral), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

The oncology field is witnessing rapid growth, owing to emergence of novel therapies with high efficacy, which in turn is boosting growth of the oncology drug pipeline market. For instance, in 2015, the U.S. Food and Drug Administration (U.S FDA) approved 45 New Molec

Coherent Market Insights
Corporate Wellness Market, by Service Type (Smoking Cessation, Weight Management, Fitness, Health Risk Assessment, Nutrition, Health Screening, and Others), by End User (Large-scale Organizations, Medium-scale Organizations, and Small-scale Organizations) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jan 2019

Corporate wellness are programs that are conducted in corporate offices to keep the employees healthy and happy, both physically and mentally. Currently, corporate wellness programs are largely adopted by employers to promote employee health, to reduce health related

Coherent Market Insights
H1N1 Vaccines Market, by Vaccine Type (Inactivated Vaccine and Live Attenuated Vaccine), by Route of Administration (Injection and Intranasal), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jan 2019

H1N1 influenza virus causes viral disease, commonly known as swine flu, which mostly affects the respiratory system. Swine flu is characterized by infection from H1N1 strain. Symptoms of H1N1 flu are fever, cough, sore throat, runny or stuffy nose, watery and red eyes

Coherent Market Insights
Tiamulin Market, by Dosage Form (Powder and Injectable), by Target Animal (Pigs, Poultry, and Others), by Distribution Channel (Veterinary Hospital, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jan 2019

Tiamulin is a pleuromutilin antibiotic drug, which is derived semi-synthetically from natural compound— pleuromutilin—originally produced by the mushroom–clitopilus scyphoides. Tiamulin is primarily used as veterinary medicine for treatment of pneumo

Coherent Market Insights
Poly Adenosine Diphosphate Ribose Polymerase Market, by Drug (Olaparib, Rucaparib, Niraparib, and Others), by Cancer Type (Prostate Cancer, Ovarian Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Jan 2019

Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as e

Coherent Market Insights
Lymphocyte Activation Gene - 3 Protein Market, by Drug (BMS-986016 (Relatlimab), IMP321, IMP701, MGD013, and Others), by Cancer Type (Breast Cancer, Melanoma, Solid Tumors, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Jan 2019

Immune checkpoint receptors such as lymphocyte activation gene - 3 (LAG-3) protein are found on cell surface of effector T cells and regulatory T cells (Tregs). T cells are a type of white blood cells that eliminate unhealthy or foreign cells that enter the immune sys

Coherent Market Insights
Testosterone Replacement Therapy Market, by Route of Administration (Injectables, Parenteral), by Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate) and by Geography -Size, Share, Outlook, and Opportunity Analysis 2018 –2026

To Be Published : Jan 2019

Testosterone Replacement Therapy (TRT) or low testosterone therapy is commonly called hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure

Coherent Market Insights
Periodontal Disease Therapeutics Market by Drug Type (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, Periochip, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) - Size, Share, Outlooks, and Opportunity Analysis 2018 - 2026

To Be Published : Jan 2019

Periodontitis is a chronic bacterial infection caused by microbial plaque often known as gum disease that is colonized on tooth surface and below the gingival margin. It involves progressive loss of the alveolar bone, which is a thickened ridge of bone that contains t

Coherent Market Insights
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market, by Disease Management (Nutritional Management and Pancreatic Enzyme Replacement Therapy (PERT)), by Therapeutic Drugs (Creon, Zenpep, Pancreaze, Ultresa, Viokace, and Others), and by Geography (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018–2026

To Be Published : Jan 2019

Exocrine pancreatic insufficiency (EPI) is a condition associated with deficiency of exocrine pancreatic enzymes that results in the inability to digest food or maldigestion. EPI may be associated with certain diseases and conditions that affect the pancreas such as c

Coherent Market Insights
Antithrombin Market, By Application (Therapeutics, Research, and Diagnostics), By Source (Human, Goat Milk, and Others), By Dosage Form (Lyophilized and Liquid), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Jan 2019

Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency

Coherent Market Insights
Nasopharyngeal Carcinoma Treatment Market, By Drug (Ellence, Taxotere, Bleomycin, and Methotrexate), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook and Opportunity Analysis 2018–2026

To Be Published : Jan 2019

Nasopharyngeal carcinoma is a rare cancer, affecting the part of throat connecting nose and mouth, known as pharynx. Nasopharyngeal carcinoma are of three types, based on cell appearance under microscope. These include keratinizing squamous cell carcinoma, non- kerati

Coherent Market Insights
Overactive Bladder Treatment Market by Drug Type (Anticholinergics (Oxybutynin, Darifenacin, Fesoterodine, Solifenacin, Tolterodine, and Trospium), Mirabegron, and Botox), by Route of Administration (Topical, Oral, and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Size, Share, Outlook and Opportunity Analysis 2018 - 2026

To Be Published : Jan 2019

Overactive bladder is a common medical condition where there is sudden urge of urination. Overactive bladder is sometimes coupled with urine leakage, condition known as incontinence. Millions of people across the globe suffers from overactive bladder and it is more co

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.